FDA Webview Site FDA Review Site FDA Updater Site
header.gif
Username:
Password:
 

human drugs
animal drugs
biologics
eirs 483s
medical devices
marketing
email
search our site
  
FDA-RELATED NEWS
 
 
 
TXT Gottleib Thanks FDA Employees as Paychecks Are Missed
01/11/2019
 
 
TXT FDA Shutdown Enters 3rd Week and Challenges Mount
01/07/2019
 
 
TXT CGMP Violations at Akorn Decatur Facility
01/10/2019
 
 
TXT New 5-Year Sentinel Strategy
01/09/2019
 
 
TXT Device Surveillance Continues During Shutdown: Gottlieb
01/11/2019
 
 
TXT Make FDA Independent: 7 Former Commissioners
01/08/2019
 
 
TXT Some Promotions Need Longer Review: OPDP
01/10/2019
 
 
TXT Gottlieb Unveils New Drug Evaluation Science Office
01/09/2019
 
 
TXT CDER Approvals Shot Up 28% in 2018: Report
01/07/2019
 
 
TXT Appeals Court Finds Lawsuit Against Supplement Maker Preempted
01/11/2019
 
 
TXT Appeals Court Affirms Medical Device Sentence
01/10/2019
 
 
TXT Woodcock Outlines Drug Safety Efforts
01/08/2019
 
 
TXT Ex-Drug Co. CEO Pleads Guilty to Bribery
01/10/2019
 
 
TXT Questioning FDA’s ‘Old Predicate’ Concern
01/08/2019
 
 
TXT Supremes Seem to Tilt to Merck in Fosamax Case
01/07/2019
 
 
TXT Since Our Last Issue ...
01/13/2019
 
 
TXT Product Approval Summaries
01/13/2019
 
 
TXT 1st Patient Being Treated Under Right-to-Try Law
01/11/2019
 
 
TXT Study: Orphan Drug Trial Costs are Half of Non-orphan Drugs
01/11/2019
 
 
TXT Top FDA Legislative Official Leaving Agency
01/11/2019
 
 
TXT Bill Would End ‘Pay for Delay’
01/10/2019
 
 
TXT Sun Pharma Recalls 4 Lots of Vecuronium Bromide
01/10/2019
 
 
TXT Sanders to Introduce Generic Drug Bill
01/10/2019
 
 
TXT Drug Prices Have to Come Down: Azar
01/09/2019
 
 
TXT Clopidogrel Boxed Warning Petition Denied
01/09/2019
 
 
TXT PhRMA Urges NDC Implementation Caution
01/09/2019
 
 
TXT Class 1 Recall of Medtronic Synergy Cranial Software
01/08/2019
 
 
TXT Medical Marketing Grows, Oversight Limited: Study
01/08/2019
 
 
TXT Software Pre-Cert Pilot Program
01/07/2019
 
 
 
 
The most authoritative FDA news analysis each week is found in the pages of Dickinson's FDA Review. Since 1984, this newsletter has been providing in-depth reports on the most significant FDA developments affecting the pharmaceutical, medical device, biologics and veterinary medicines industries. Unlike other media, FDA Review eliminates time-wasting minutia and presents in clear, concise language the essence of what's really important - and why. It is the publication that FDA officials themselves read. Delivered in the middle of each week, FDA Review presents:
  • The latest agency policy developments, often before they're officially announced;
  • Major news insights, follow-ups and reactions in each product area;
  • Summaries of the latest Warning Letters;
  • The newest product approvals;
  • Summaries of the latest FDA Federal Register notices;
  • Summaries of DDMAC letters;
  • Related industry news capsules;
  • The industry's most concise FDA news index;
  • Inside-FDA news briefs
You can rely on FDA Review to provide only what's important - in the most convenient and time-saving